ProfileGDS4718 / 238581_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 21% 21% 17% 17% 24% 16% 44% 23% 21% 16% 16% 29% 36% 21% 41% 19% 13% 32% 16% 25% 17% 18% 30% 19% 22% 23% 18% 10% 32% 20% 24% 35% 17% 20% 22% 26% 19% 41% 19% 23% 14% 22% 31% 18% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.1848921
GSM549102patient 115, normal, homogenized [OPG study]4.1999721
GSM549104patient 119, normal, homogenized [OPG study]3.9964117
GSM549108patient 138, normal, homogenized [OPG study]4.0489517
GSM549119patient 077, normal, homogenized [OPG study]4.3034624
GSM549133patient 032, cancer, homogenized [OPG study]3.9463516
GSM549139patient 042, cancer, homogenized [OPG study]5.1450344
GSM549099patient 107, normal, homogenized [OPG study]4.2946223
GSM549109patient 139, normal, homogenized [OPG study]4.1991621
GSM549110patient 046, normal, homogenized [OPG study]4.0090916
GSM549114patient 063, normal, homogenized [OPG study]3.9519616
GSM549122patient 082, normal, homogenized [OPG study]4.5213429
GSM549134patient 033, cancer, homogenized [OPG study]4.786936
GSM549136patient 036, cancer, homogenized [OPG study]4.137421
GSM549140patient 044, cancer, homogenized [OPG study]4.9907641
GSM549111patient 047, normal, homogenized [OPG study]4.070419
GSM549113patient 057, normal, homogenized [OPG study]3.8595913
GSM549132patient 031, cancer, homogenized [OPG study]4.5911932
GSM549137patient 038, cancer, homogenized [OPG study]3.9898416
GSM549142patient 047, cancer, homogenized [OPG study]4.4448325
GSM549100patient 110, normal, homogenized [OPG study]4.0246717
GSM549107patient 135, normal, homogenized [OPG study]4.0418518
GSM549115patient 068, normal, homogenized [OPG study]4.4824730
GSM549116patient 072, normal, homogenized [OPG study]4.1026619
GSM549120patient 078, normal, homogenized [OPG study]4.2054822
GSM549131patient 030, cancer, homogenized [OPG study]4.2263623
GSM549118patient 074, normal, homogenized [OPG study]4.0939418
GSM549129patient 027, cancer, homogenized [OPG study]3.7801810
GSM549123patient 088, normal, homogenized [OPG study]4.5882732
GSM549124patient 006, cancer, homogenized [OPG study]4.1936220
GSM549126patient 015, cancer, homogenized [OPG study]4.2697324
GSM549128patient 025, cancer, homogenized [OPG study]4.7461135
GSM549103patient 117, normal, homogenized [OPG study]4.0765917
GSM549117patient 073, normal, homogenized [OPG study]4.1187120
GSM549138patient 041, cancer, homogenized [OPG study]4.1953222
GSM549141patient 045, cancer, homogenized [OPG study]4.3111826
GSM549130patient 028, cancer, homogenized [OPG study]4.1072919
GSM549101patient 111, normal, homogenized [OPG study]5.0723741
GSM549105patient 128, normal, homogenized [OPG study]4.1178119
GSM549106patient 134, normal, homogenized [OPG study]4.2172823
GSM549112patient 048, normal, homogenized [OPG study]3.9270114
GSM549125patient 011, cancer, homogenized [OPG study]4.2495122
GSM549127patient 024, cancer, homogenized [OPG study]4.5492431
GSM549135patient 035, cancer, homogenized [OPG study]4.0102518